Wischik, Claude MWischik, Damon JStorey, John M DHarrington, Charles RMartinez, Ana2014-12-032014-12-032010Wischik, C M, Wischik, D J, Storey, J M D & Harrington, C R 2010, Rationale for tau aggregation inhibitor therapy in Alzheimer's disease and other tauopathies. in A Martinez (ed.), Emerging drugs and targets for Alzheimer's disease : Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism. vol. 1, RSC Drug Discovery Series, Cambridge, pp. 210-232. https://doi.org/10.1039/9781849731065978-1-84973-106-5ORCID: /0000-0002-5261-5467/work/73579127ORCID: /0000-0003-2250-3920/work/47672896http://hdl.handle.net/2164/4066231546681engRM Therapeutics. PharmacologyRMBook item10.1039/97818497310651